Dieter Schweiss

Title: The Innovative Contributions of Dieter Schweiss

Introduction

Dieter Schweiss is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibacterial compounds. With a total of 2 patents, his work has had a meaningful impact on medical science.

Latest Patents

Schweiss's latest patents include the development of substituted-1,2-dihydro-2-oxonicotinyl-cephalosporins. These novel organic amide compounds are designed to provide broad-spectrum antibacterial utility. The process involves reacting the free amino acid of the appropriate penicillin or cephalosporin with a reactive derivative of the corresponding N-6-[(substituted amino)phenyl]-1,2-dihydro-2-oxonicotinic acid. Additionally, pharmaceutical compositions containing these compounds and methods for treating infections using these compositions are also disclosed.

Career Highlights

Dieter Schweiss has worked at Parke, Davis & Company, where he has been able to apply his innovative ideas in a collaborative environment. His contributions have been instrumental in advancing the company's pharmaceutical research and development efforts.

Collaborations

Some of his notable coworkers include Leonard Doub and James S. Kaltenbronn. Their collaborative efforts have further enhanced the research and development of new pharmaceutical compounds.

Conclusion

Dieter Schweiss's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations have paved the way for advancements in antibacterial treatments, showcasing the importance of research and development in healthcare.